FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2894465451> ?p ?o ?g. }

• W2894465451 abstract "APS is an autoimmune disease in which antiphospholipid antibodies (aPL) cause vascular thrombosis and pregnancy morbidity. In patients with APS, aPL exert pathogenic actions by binding serum beta-2-glycoprotein I (2GPI) via its N-terminal domain I (DI). We previously showed that bacterially-expressed recombinant DI inhibits biological actions of IgG derived from serum of patients with APS (APS-IgG). DI is too small (7kDa) to be a viable therapeutic agent. Addition of polyethylene glycol (PEGylation) to small molecules enhances the serum half-life, reduces proteolytic targeting and can decrease immunogenicity. It is a common method of tailoring pharmacokinetic parameters and has been used in the production of many therapies in the clinic. However, PEGylation of molecules may reduce their biological activity, and the size of the PEG group can alter the balance between activity and half-life extension. Here we achieve production of site-specific PEGylation of recombinant DI (PEG-DI) and describe the activities in vitro and in vivo of three variants with different size PEG groups. All variants were able to inhibit APS-IgG from: binding to whole 2GPI in ELISA, altering the clotting properties of human plasma and promoting thrombosis and tissue factor expression in mice. These findings provide an important step on the path to developing DI into a first-in-class therapeutic in APS." @default.
• W2894465451 created "2018-10-05" @default.
• W2894465451 creator A5010606993 @default.
• W2894465451 creator A5013104655 @default.
• W2894465451 creator A5024237017 @default.
• W2894465451 creator A5033602979 @default.
• W2894465451 creator A5041543434 @default.
• W2894465451 creator A5042523412 @default.
• W2894465451 creator A5043164143 @default.
• W2894465451 creator A5056656832 @default.
• W2894465451 creator A5057848962 @default.
• W2894465451 creator A5061036069 @default.
• W2894465451 creator A5061811610 @default.
• W2894465451 creator A5065798696 @default.
• W2894465451 creator A5091574164 @default.
• W2894465451 date "2018-10-22" @default.
• W2894465451 modified "2023-09-26" @default.
• W2894465451 title "PEGylated Domain I of Beta-2-Glycoprotein I Inhibits the Binding, Coagulopathic, and Thrombogenic Properties of IgG From Patients With the Antiphospholipid Syndrome" @default.
• W2894465451 cites W1512626895 @default.
• W2894465451 cites W1635457043 @default.
• W2894465451 cites W1922557247 @default.
• W2894465451 cites W1965918908 @default.
• W2894465451 cites W1982188484 @default.
• W2894465451 cites W1991901335 @default.
• W2894465451 cites W1992107281 @default.
• W2894465451 cites W2005807432 @default.
• W2894465451 cites W2006566716 @default.
• W2894465451 cites W2024343545 @default.
• W2894465451 cites W2029241430 @default.
• W2894465451 cites W2038069098 @default.
• W2894465451 cites W2048790796 @default.
• W2894465451 cites W2054330426 @default.
• W2894465451 cites W2058614095 @default.
• W2894465451 cites W2062466582 @default.
• W2894465451 cites W2065876461 @default.
• W2894465451 cites W2069995085 @default.
• W2894465451 cites W2070760253 @default.
• W2894465451 cites W2084587462 @default.
• W2894465451 cites W2094704598 @default.
• W2894465451 cites W2098313122 @default.
• W2894465451 cites W2099199787 @default.
• W2894465451 cites W2101019557 @default.
• W2894465451 cites W2101326680 @default.
• W2894465451 cites W2113197903 @default.
• W2894465451 cites W2113891001 @default.
• W2894465451 cites W2143891179 @default.
• W2894465451 cites W2155433659 @default.
• W2894465451 cites W2162332961 @default.
• W2894465451 cites W2163817180 @default.
• W2894465451 cites W2175884095 @default.
• W2894465451 cites W2416636197 @default.
• W2894465451 cites W2492117096 @default.
• W2894465451 cites W2514539105 @default.
• W2894465451 cites W2742548756 @default.
• W2894465451 cites W2813643485 @default.
• W2894465451 cites W630513080 @default.
• W2894465451 doi "https://doi.org/10.3389/fimmu.2018.02413" @default.
• W2894465451 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6204385" @default.
• W2894465451 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30405613" @default.
• W2894465451 hasPublicationYear "2018" @default.
• W2894465451 type Work @default.
• W2894465451 sameAs 2894465451 @default.
• W2894465451 citedByCount "11" @default.
• W2894465451 countsByYear W28944654512019 @default.
• W2894465451 countsByYear W28944654512020 @default.
• W2894465451 countsByYear W28944654512021 @default.
• W2894465451 countsByYear W28944654512022 @default.
• W2894465451 countsByYear W28944654512023 @default.
• W2894465451 crossrefType "journal-article" @default.
• W2894465451 hasAuthorship W2894465451A5010606993 @default.
• W2894465451 hasAuthorship W2894465451A5013104655 @default.
• W2894465451 hasAuthorship W2894465451A5024237017 @default.
• W2894465451 hasAuthorship W2894465451A5033602979 @default.
• W2894465451 hasAuthorship W2894465451A5041543434 @default.
• W2894465451 hasAuthorship W2894465451A5042523412 @default.
• W2894465451 hasAuthorship W2894465451A5043164143 @default.
• W2894465451 hasAuthorship W2894465451A5056656832 @default.
• W2894465451 hasAuthorship W2894465451A5057848962 @default.
• W2894465451 hasAuthorship W2894465451A5061036069 @default.
• W2894465451 hasAuthorship W2894465451A5061811610 @default.
• W2894465451 hasAuthorship W2894465451A5065798696 @default.
• W2894465451 hasAuthorship W2894465451A5091574164 @default.
• W2894465451 hasBestOaLocation W28944654511 @default.
• W2894465451 hasConcept C104317684 @default.
• W2894465451 hasConcept C108625454 @default.
• W2894465451 hasConcept C150903083 @default.
• W2894465451 hasConcept C159654299 @default.
• W2894465451 hasConcept C185592680 @default.
• W2894465451 hasConcept C203014093 @default.
• W2894465451 hasConcept C207001950 @default.
• W2894465451 hasConcept C2776874634 @default.
• W2894465451 hasConcept C2776964284 @default.
• W2894465451 hasConcept C2779149719 @default.
• W2894465451 hasConcept C2780868878 @default.
• W2894465451 hasConcept C40767141 @default.
• W2894465451 hasConcept C55493867 @default.
• W2894465451 hasConcept C71924100 @default.
• W2894465451 hasConcept C86803240 @default.
• W2894465451 hasConcept C98274493 @default.
• W2894465451 hasConceptScore W2894465451C104317684 @default.

• next